SEROEPIDEMIOLOGY OF HEPATITIS-B VIRUS-INFECTION IN SAUDI-ARABIAN CHILDREN - A BASE-LINE SURVEY FOR MASS VACCINATION AGAINST HEPATITIS-B

被引:63
作者
ALFALEH, FZ
AYOOLA, EA
ARIF, M
RAMIA, S
ALRASHED, R
ALJEFFRY, M
ALMOFARREH, M
ALKARAWI, M
ALSHABRAWY, M
机构
[1] KING SAUD UNIV, KING KHALID UNIV HOSP, RIYADH, SAUDI ARABIA
[2] COLL MED RIYADH, RIYADH, SAUDI ARABIA
[3] MINIST HLTH, RIYADH, SAUDI ARABIA
[4] SOCIAL INSURANCE INST, RIYADH, SAUDI ARABIA
[5] RIYADH ARMED FORCES HOSP, RIYADH, SAUDI ARABIA
关键词
D O I
10.1016/0163-4453(92)93006-C
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Saudi Arabia is considered to be an area of endemic hepatitis B virus (HBV) infection. By adult age, 7 % persons have hepatitis B surface antigen (HBsAg) and about 70 % have one or more HBV markers. In order to provide a baseline for the integration of hepatitis B vaccine into the extended programme of immunisation (EPI), a population-based survey of HBV markers was made among Saudi children. The overall prevalence of HBsAg was 6·7 %, with at least one HBV marker being positive in 19·7 % persons tested. Two peaks of HBV prevalence were observed in the 7- and 10year-old children respectively. The prevalence of HBsAg was steady in all age groups with identifiable but insignificant peaks in children aged 4 and 7 years respectively. Despite the apparent homogeneity of the Saudi population, the prevalence rates of HBV varied among the regions and were higher in urban dwellers. There was no significant difference in the HBsAg prevalence for the sexes (7·3 % for males and 6·0 % for females). Socioeconomic factors and family size did not significantly influence the prevalence of HBV among children. Of 307 HBsAg-positive children, 55 (17·9%) were positive for HBsAg. The early acquisition of HBV in the Saudi population is confirmed. The most effective strategy for HBV control, therefore, is by mass vaccination of all Saudi infants. An extension of the immunisation programme so as to include all pre-school children should further reduce the reservoir of HBV in Saudi Arabia. A repetition of a similar survey after 5 and in years should be made in order to measure this reduction. © 1992 The British Society for the Study of Infection.
引用
收藏
页码:197 / 206
页数:10
相关论文
共 25 条
[1]  
Abdurrahman M. B., 1984, Saudi Medical Journal, V5, P369
[2]  
Al-Faleh FZ, 1990, 1990 S VIR HEP LIV D
[3]   HEPATITIS B-INFECTION IN SAUDI-ARABIA [J].
ALFALEH, FZ .
ANNALS OF SAUDI MEDICINE, 1988, 8 (06) :474-480
[4]   HEPATITIS-B VIRUS IN GIZAN, SAUDI-ARABIA [J].
ARVA, SC ;
ASHRAF, SJ ;
PARANDE, CM ;
ELSAYED, M ;
SAHAY, R ;
AGEEL, AR ;
TOBEIQI, MS .
JOURNAL OF MEDICAL VIROLOGY, 1985, 17 (03) :267-274
[5]  
ASHRAF SJ, 1986, CANCER-AM CANCER SOC, V58, P2163, DOI 10.1002/1097-0142(19861101)58:9<2163::AID-CNCR2820580934>3.0.CO
[6]  
2-2
[7]  
AYOOLA EA, VIRAL HEPATITIS LIVE, P161
[8]  
Barin F, 1981, Prog Med Virol, V27, P148
[9]   MATERNO-FETAL TRANSMISSION OF HEPATITIS-B IN SAUDI-ARABIA [J].
BASALAMAH, AH ;
SEREBOUR, F ;
KAZIM, E .
JOURNAL OF INFECTION, 1984, 8 (03) :200-204
[10]  
BEASLEY RP, 1981, LANCET, V2, P1129